Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

Chlamydia Trachomatis Antikörper (HRP)

Reaktivität: Chlamydia trachomatis EIA Wirt: Kaninchen Polyclonal HRP
Produktnummer ABIN112695
  • Target Alle Chlamydia Trachomatis Produkte
    Chlamydia Trachomatis
    Reaktivität
    • 45
    • 1
    Chlamydia trachomatis
    Wirt
    • 16
    • 15
    • 13
    • 1
    • 1
    Kaninchen
    Klonalität
    • 30
    • 16
    Polyklonal
    Konjugat
    • 26
    • 9
    • 6
    • 5
    Dieser Chlamydia Trachomatis Antikörper ist konjugiert mit HRP
    Applikation
    • 27
    • 22
    • 20
    • 14
    • 10
    • 5
    • 4
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    Enzyme Immunoassay (EIA)
    Produktmerkmale
    Molar Ratio: Estimated molar HRP: IgG substitution is 2-3.
    Immunogen
    L2 + other serovar groups
  • Applikationshinweise
    Suitable for use in ELISA and immunocytochemistry.
    Other applications not tested.
    Optimal dilutions are dependent on conditions and should be determined by the user.
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Konzentration
    1-2 mg/mL (OD280 nm, E0.1% = 1.4)
    Buffer
    PBS containing 10 mg/mL BSA as stabilizer and 0.002 % Thimerosal as preservative.
    Konservierungsmittel
    Thimerosal (Merthiolate)
    Vorsichtsmaßnahmen
    This product contains thimerosal (merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Handhabung
    Avoid repeated freezing and thawing.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
  • Target
    Chlamydia Trachomatis
    Abstract
    Chlamydia Trachomatis Produkte
    Substanzklasse
    Bacteria
    Hintergrund
    Chlamydia trachomatis is an intracellular organism. Chlamydia usually infects the cervix and fallopian tubes of women and the urethra of men. Chlamydial infections are believed to be one of the most common of all STDs. It is generally thought that in a population of 15 million, there are up to 300,000 cases of chlamydia each year. Thus, there are many undiagnosed cases of chlamydia in the community. It has been estimated that the true prevalence of chlamydia in the sexually active population may be in the order of 5 % to 10 %. Chlamydia is one of the leading causes of blindness in underdeveloped countries.
Sie sind hier:
Kundenservice